Phase II trial of sequential gefitinib after minor response or partial response to chemotherapy in Chinese patients with advanced non-small-cell lung cancer
2006 · BMC Cancer · 5 citations
https://doi.org/10.1186/1471-2407-6-288
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
0
Papers
0
Citations
Yue Min Li is an academic researcher.
Click to start Chat